Lansdon, Eric B.

New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action

Tsiang, M., Jones, G. S., Niedziela-Majka, A., Kan, E., Lansdon, E. B., Huang, W., Hung, M., Samuel, D., Novikov, N., Xu, Y., et al. (2012) · Journal of Biological Chemistry

HIV/AIDS drug development and treatmentHIV Research and Treatment

Cited by 167

Visualizing the molecular interactions of a nucleotide analog, GS-9148, with HIV-1 reverse transcriptase-DNA complex

Lansdon, E. B., Samuel, D., Lagpacan, L., Brendza, K. M., White, K. L., Hung, M., Liu, X., Boojamra, C. G., Mackman, R. L., Cihlar, T., et al. (2010) · Journal of Molecular Biology

HIV/AIDS drug development and treatmentEnzyme Structure and Function

Cited by 49

Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase—structure-activity relationships and crystallographic analysis

Kirschberg, T. A., Balakrishnan, M., Huang, W., Hluhanich, R., Kutty, N., Liclican, A. C., McColl, D. J., Squires, N. H., & Lansdon, E. B. (2008) · Bioorganic & Medicinal Chemistry Letters

HIV/AIDS drug development and treatmentSynthesis and Characterization of Heterocyclic Compounds

Cited by 38

A structural roadmap for the formation of the coronavirus nsp3/nsp4 double membrane vesicle pore and its implications for polyprotein processing and replication/transcription

Perry, J. K., Itskanov, S., Bilello, J. P., & Lansdon, E. B. (2025) · Journal of Virology

SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studies

Cited by 6